Literature DB >> 21856956

The business case for quality: economic analysis of the Michigan Keystone Patient Safety Program in ICUs.

Hugh R Waters1, Roy Korn, Elizabeth Colantuoni, Sean M Berenholtz, Christine A Goeschel, Dale M Needham, Julius C Pham, Allison Lipitz-Snyderman, Sam R Watson, Patricia Posa, Peter J Pronovost.   

Abstract

Health care-associated infections affect an estimated 5% of hospitalized patients and represent one of the leading causes of illness and death in the United States. This study calculates the costs and benefits of a patient safety program in intensive care units in 6 hospitals that were part of the Michigan Keystone ICU Patient Safety Program. On average, 29.9 catheter-related bloodstream infections and 18.0 cases of ventilator-associated pneumonia were averted per hospital on an annual basis. The average cost of the intervention is $3375 per infection averted, measured in 2007 dollars. The cost of the intervention is substantially less than estimates of the additional health care costs associated with these infections, which range from $12 208 to $56 167 per infection episode. These results do not take into account the additional effect of the Michigan Keystone program in terms of reducing cases of sepsis or its effects in terms of preventing mortality, improving teamwork, and reducing nurse turnover.

Entities:  

Mesh:

Year:  2011        PMID: 21856956     DOI: 10.1177/1062860611410685

Source DB:  PubMed          Journal:  Am J Med Qual        ISSN: 1062-8606            Impact factor:   1.852


  18 in total

1.  Small Ideas for Saving Big Health Care Dollars.

Authors:  Jodi L Liu; Deborah Lai; Jeanne S Ringel; Mary E Vaiana; Jeffrey Wasserman
Journal:  Rand Health Q       Date:  2014-03-01

2.  Eliminating Infections in the ICU: CLABSI.

Authors:  Asad Latif; Muhammad Sohail Halim; Peter J Pronovost
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

3.  A decade of investment in infection prevention: a cost-effectiveness analysis.

Authors:  Andrew W Dick; Eli N Perencevich; Monika Pogorzelska-Maziarz; Jack Zwanziger; Elaine L Larson; Patricia W Stone
Journal:  Am J Infect Control       Date:  2015-01       Impact factor: 2.918

4.  A Model of Organizational Context and Shared Decision Making: Application to LGBT Racial and Ethnic Minority Patients.

Authors:  Rachel H DeMeester; Fanny Y Lopez; Jennifer E Moore; Scott C Cook; Marshall H Chin
Journal:  J Gen Intern Med       Date:  2016-06       Impact factor: 5.128

5.  Why patients need leaders: introducing a ward safety checklist.

Authors:  Yogen Amin; Dave Grewcock; Steve Andrews; Aidan Halligan
Journal:  J R Soc Med       Date:  2012-09       Impact factor: 5.344

6.  Attributable cost and length of stay for central line-associated bloodstream infections.

Authors:  Anthony Goudie; Linda Dynan; Patrick W Brady; Mallikarjuna Rettiganti
Journal:  Pediatrics       Date:  2014-05-05       Impact factor: 7.124

7.  Evaluation of the Effectiveness of a Surgical Checklist in Medicare Patients.

Authors:  Bradley N Reames; Christopher P Scally; Jyothi R Thumma; Justin B Dimick
Journal:  Med Care       Date:  2015-01       Impact factor: 2.983

8.  Accelerating Improvement in Children's Healthcare Through Quality Improvement Collaboratives: A Synthesis of Recent Efforts.

Authors:  Michael Terao; James M Hoffman; Richard J Brilli; Amanda Finch; Kathleen E Walsh; Maitreya Coffey
Journal:  Curr Treat Options Pediatr       Date:  2019-05-04

9.  Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample.

Authors:  Andreas Becker; Marco Bianchi; Jens Hansen; Zhe Tian; Shahrokh F Shariat; Ioana Popa; Paul Perrotte; Quoc-Dien Trinh; Pierre I Karakiewicz; Maxine Sun
Journal:  World J Urol       Date:  2014-02-11       Impact factor: 4.226

Review 10.  Economic Evaluation of Quality Improvement Interventions for Bloodstream Infections Related to Central Catheters: A Systematic Review.

Authors:  Teryl K Nuckols; Emmett Keeler; Sally C Morton; Laura Anderson; Brian Doyle; Marika Booth; Roberta Shanman; Jonathan Grein; Paul Shekelle
Journal:  JAMA Intern Med       Date:  2016-12-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.